BAFF has been previously studied in patients with autoimmune diseases, including rheumatoid arthritis and lupus [7,8], which exhibit a strong predisposition to premature atherosclerosis and heart attacks [4]. This evidence concerns the gene TNFSF13B and systemic lupus erythematosus.